Venous thromboembolism in children: Rivaroxaban effective and safe even with extended use. Venous thromboembolism (VTE) is a life-threatening complication in children with serious underlying conditions such as heart defects or cancer. Treatment or prevention of thrombosis poses an additional challenge in everyday clinical practice. A therapy using the active ingredient rivaroxaban specifically tailored to children […]
Combination of drugs could prevent thousands of heart attacks; Patients who receive an add-on medication soon after a heart attack have a significantly better prognosis than those who receive it later, or not all. This is according to a new study from researchers at Lund University in Sweden and Imperial College London. The findings suggest that […]
Read More… from Combination of drugs could prevent thousands of heart attacks
Patients who contract COVID-19 face a higher risk of developing cardiovascular diseases and diabetes, a new study by Kings College London has found. The risk was higher in the three months following infection, and returns to baseline after 23 weeks for diabetes, and seven weeks for cardiovascular diseases. This means there is not a long-term […]
Read More… from Risk of cardiovascular diseases and diabetes higher for COVID-19 patients
Vascular disease in COVID-19 is not caused by viral infection of blood vessels: The SARS-CoV-2 virus does not infect blood vessels, despite the high risk of blood clots to COVID-19 patients, University of Queensland researchers have found. Dr Emma Gordon and Dr Larisa Labzin from UQ’s Institute for Molecular Bioscience and Dr Kirsty Short from UQ’s School of Chemistry and Molecular Biosciences pooled their […]
Read More… from Vascular disease in COVID-19 is not caused by viral infection of blood vessels